Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    " December 24, 2008":" January 23, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" December 24, 2008":" January 23, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (28 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
Condition: Human Immunodeficiency Virus-1
Intervention: Drug: maraviroc
2 Completed Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV
Conditions: Peripheral Neuropathy;   HIV;   AIDS;   HIV Infections
Interventions: Other: Acupuncture / Moxibustion;   Other: Acupuncture/Moxibustion
3 Completed Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: maraviroc (Selzentry, Celsentri)
4 Unknown  Effective Aids Treatment and Support in the Free State (FEATS)
Conditions: HIV/AIDS;   Food Insecurity;   HIV Infections
Interventions: Behavioral: ARV peer adherence support (PAS);   Dietary Supplement: Nutritional support;   Drug: ARV treatment
5 Unknown  Alveolar Macrophage Proteomics in HIV-associated Emphysema
Conditions: HIV;   Emphysema;   HIV Infections
Intervention:
6 Completed TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer
Conditions: Tuberculosis;   HIV
Intervention: Drug: TMC207
7 Completed VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
Conditions: Hepatitis C;   HCV;   HIV;   AIDS
Intervention: Drug: Efavirenz; Tenofovir disoproxil fumarate; Telaprevir
8 Completed TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.
Conditions: HIV;   Pharmacokinetics
Intervention: Drug: TMC125
9 Completed Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: Placebo;   Biological: rMVA vaccine
10 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
Intervention:
11 Completed Renal Function Assessment in HIV Patient
Conditions: Chronic Kidney Disease;   HIV Infections
Intervention: Other: DEXA scan
12 Completed Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: raltegravir
13 Recruiting The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
Conditions: Cancer;   HIV Infections
Intervention:
14 Terminated
Has Results
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Condition: HIV-1
Intervention: Drug: No drug will be administered
15 Completed
Has Results
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Condition: HIV-1
Interventions: Drug: UK-453, 061;   Drug: EFV +TVA
16 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:
17 Completed Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
Conditions: HIV/AIDS;   HIV Infections
Intervention: Drug: ETHINYL ESTRADIOL AND LEVOGESTREL
18 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
19 Terminated
Has Results
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
Interventions: Drug: UK-453,061 Dose 1;   Drug: UK-453,061 Dose 2;   Drug: Etravirine
20 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years